Please adjust your “the players union is only interested in protecting drug cheats” rhetoric appropriately. Because as Michael Weiner told the New York Daily News yesterday, that’s not the m.o. of his union with respect to the Biogenesis stuff:
“I can tell you, if we have a case where there really is overwhelming evidence, that a player committed a violation of the program, our fight is going to be that they make a deal,” Weiner said without referring to specific players. “We’re not interested in having players with overwhelming evidence that they violated the (drug) program out there. Most of the players aren’t interested in that. We’d like to have a clean program.”
One should assume that Weiner and the MLBPA will fight cases with which there are legitimate disputes as to culpability, and one should also assume that they will defend the due process rights of everyone involved, but the days where it’s 100% scorched-Earth between the league and the union are a long way in the rear-view mirror, so it shouldn’t be surprising that Weiner is taking a pragmatic approach here as well.
The interesting question will be if a player falls under Weiner’s “overwhelming evidence” category and still decides to fight. I presume he’d do so with his own legal team. And I presume the union would be issuing lots of awkward statements trying to both distance itself from the defense and respect the process. But that will sure be hard after these statements.
David Price is reported to have a “barking” elbow and it is expected that the Red Sox will scratch him from tonight’s start against the Royals in Boston. Dan Shaughnessy reports that the elbow soreness is similar to what he was feeling in the spring and that the Red Sox may place him on the disabled list. UPDATE: Buster Olney reports that the Red Sox gave Price an MRI yesterday.
Price was knocked around for six runs — five earned — in five innings against the Angels in his last start. He was also the subject of controversy soon after that after Shaughnessy reported the details of his run-in with Dennis Eckersley on the Sox team plane in June. That incident and his elbow are obviously separate things, but that’s not stopping the talk radio from people using the report of Price’s elbow to question is fortitude and stuff. Which is dumb, even if it is predictable. If you want to question Price’s character, fine, but to suggest that it’s related to his health is a silly way to go about it.
Price is 5-3 with a 3.82 ERA and a 63/22 K/BB ratio in 66 innings across 11 starts this year. The Red Sox are a half game up on the Yankees in the AL East.
There was a lot of talk yesterday that the New York Yankees and the Oakland A’s were close to a Sonny Gray deal, but that seems to be at an impasse now, as Jon Heyman reports that the A’s want either either Clint Frazier or Gleyber Torres and the Yankees say both of those prospects are off limits.
Frazier, who has held his own with a .284/.299/.541 line since his callup at the beginning of the month, is a key part of the Yankees future or — if you think Brian Cashman is bluffing here — a prime trade chit for someone better than Sonny Gray. Torres, despite his season ending due to Tommy John surgery following a freak play, is widely considered the Yankees shortstop of the future. Again, no one is untouchable in the right deal, but it’s an open question as to whether Sonny Gray is really the guy you burn your top prospects for.
There are lesser pitchers for whom the Yankees could trade, such as Jaime Garcia. Or, if they want to take a chance on a rental, they could go after Yu Darvish. But at the moment it does not seem like a Gray-to-New York deal is gonna happen.